CNS Pharmaceuticals Inc CNSP:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 04/24/24 EDT
0.214quote price arrow up+0.004 (+1.9048%)
Volume
75,701
52 week range
0.19 - 2.98
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.214
  • 52 Week High2.98
  • 52 Week High Date06/02/23
  • 52 Week Low0.19
  • 52 Week Low Date04/17/24

Key Stats

  • Market Cap2.276M
  • Shares Out10.63M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change-83.15

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.214
  • 52 Week High2.98
  • 52 Week High Date06/02/23
  • 52 Week Low0.19
  • 52 Week Low Date04/17/24
  • Market Cap2.276M
  • Shares Out10.63M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change-83.15

RATIOS/PROFITABILITY

  • EPS (TTM)-5.76
  • P/E (TTM)-0.04
  • Fwd P/E (NTM)-0.09
  • EBITDA (TTM)-18.861M
  • ROE (TTM)-1,018.78%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-6.79%

EVENTS

  • Earnings Date05/15/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CNS Pharmaceuticals Inc

 

Content From Our Affiliates

Profile

MORE
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system (CNS). The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for the treatment of a number of serious brain and CNS oncology indications, including...
Faith Charles J.D.
Independent Non-Executive Chairman of the Board
John Climaco Esq.
Chief Executive Officer, Director
Christopher Downs CPA
Chief Financial Officer
Address
2100 West Loop S Ste 900
Houston, TX
77027-3522
United States

Top Peers

SYMBOLLASTCHG%CHG
DRMA
Dermata Therapeutics Inc
0.3568+0.0171+5.0339%
SLRX
Salarius Pharmaceuticals Inc
0.508+0.007+1.3972%
PRFX
PainReform Ltd
0.857-0.0328-3.6862%
GLMD
Galmed Pharmaceuticals Ltd
0.40+0.0386+10.6807%
ELOX
Eloxx Pharmaceuticals Inc
0.81UNCHUNCH